Hefei Lifeon Pharmaceutical Company Description

Hefei Lifeon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients in China and internationally.

The company offers active pharmaceutical ingredients, which includes felodipine, urea, paeonol, doxazosin mesylate, prilocaine, nifedipine, azilsartan kamedoxomil, methylphenidate hydrochloride, dexmethylphenidate HCL, dioctyl sulfosuccinate sodium salt, and DMSA.

It also provides intermediate products, such as sodium paeonolsilate, methy2-(2,3-dichlorobenzylidine)-acetoacetate, 3-mercapto-1-propanol, mercaptosuccinic acid and DMPS monohydrate.

In addition, it offers nifedipine controlled, doxazosin mesylate, felodipine, trimetazidine dihydrochloride prolonged, and paliperidone release tablets; venlafaxine, methylphenidate, and oxycodone hydrochloride prolonged release tablets; chinese medicines; and proxymetacaine hydrochloride, bendazac lysine, timolol maleate, gatifloxacin, jinzhen, pemirolast potassium, and compound dextran 70 eye drops.

Further, it provides paeonol ointment, kecuo yintong gel, compound tujingpi gel, metformin and glipizide tablets, and itraconazole and armillarisin oral solution.

The company was incorporated in 2002 and is based in Hefei, China.

Hefei Lifeon Pharmaceutical Co., Ltd.

Country	China
Founded	2002
Industry	Biotechnology
Sector	Healthcare
Employees	1,456
CEO	Huanxi Cui

Contact Details

Address: Cube Factory Hefei, 230088 China
Phone	86 551 6535 0370
Website	lifeonapi.com

Stock Details

Ticker Symbol	003020
Exchange	Shenzhen Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE100004BD9
SIC Code	2834

Key Executives

Name	Position
Huanxi Cui	General Manager
Shaobing Gou	Financial Director
Jun Chen	R&D Director and Non-Independent Director
Qing Wang	Deputy GM and Non-Independent Director
Tianhe Dai	Deputy General Manager
Jun Xia	Deputy GM and Secretary of the Board